Autor/in Fallowfield, L 2 Gligorov, J Jenkins, V 2 Müller, V Osborne, S 2 Pivot, X 2 Verma, S 2 Curigliano, G 1 Knoop, A 1 Lichinitser, M 1 Machackova, Z 1 Scotto, N 1 Sánchez Muñoz, A 1 alle zeigenListe einklappen
Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study Pivot, X Verma, S Fallowfield, L Müller, V Lichinitser, M Jenkins, V Sánchez Muñoz, A 2017 - Forschungsinformationssystem des UKE
Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study Pivot, X Gligorov, J Müller, V Curigliano, G Knoop, A Verma, S Jenkins, V 2014 - Forschungsinformationssystem des UKE